Brigham and Women’s Hospital is testing a nasal vaccine for Alzheimer’s disease

Facebook
Twitter
LinkedIn

Brigham and Women’s Hospital is in the early stages of testing a new nasal vaccine to fight Alzheimer’s disease, a neurological disorder that impacts the memory and mental function of more than 6 million Americans.

PDF not loading below? Click here to refresh the page.

Upcoming Research Events

Research & Innovation News